Use Of VR In Curtailing Pain At The Time Of Medical Procedures To Drive The Microfluidic Devices Market
The global microfluidic devices market was valued at US$ 5.1 Bn in 2020, and is estimated to surge at a CAGR of 24% during the forecast period of 2021-2031. The market in the European region is expected to expand at a reasonable CAGR of around 14%, with global demand expected to reach US$ 21.5 Bn by the end of 2031. Globally, the microfluidic devices market is witnessing significant growth due to increasing R&D investment in pharmaceuticals, life science and rising point of care testing demand. New trends in healthcare, such as health care at home, supports point of care testing (POCT) as the most efficient and effective delivery of healthcare. Miniaturization also reduces the cost for screening compounds in pharmaceutical companies for cell biology problems. In addition, microfluidic proteomic devices are increasingly being used to quantify and identify proteins and to study interactions of different proteins with reagent in array. Different materials such as g...